Reply: A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization

Affiliations

Free article

Comment

Marnix G E H Lam et al. J Nucl Med. 2013 Dec.

Free article

. 2013 Dec;54(12):2192-3.

doi: 10.2967/jnumed.113.132852. Epub 2013 Nov 6.

¹ University Medical Center Utrecht Heidelberglaan 100 3584 CX Utrecht, The Netherlands. E-mail: m.lam@umcutrecht.nl.

No abstract available

Comment on

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, Nijsen JF, Lam MG. Wondergem M, et al. J Nucl Med. 2013 Aug;54(8):1294-301. doi: 10.2967/jnumed.112.117614. Epub 2013 Jun 7. J Nucl Med. 2013. PMID: 23749996
A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization.
Kao YH. Kao YH. J Nucl Med. 2013 Dec;54(12):2191-2. doi: 10.2967/jnumed.113.128553. Epub 2013 Nov 6. J Nucl Med. 2013. PMID: 24198389 No abstract available.